Cross‐sectional survey of biosimilar insulin utilization in Asia: The Joint Asia Diabetes Evaluation Program

AIMS/INTRODUCTION: Biosimilar insulin can reduce treatment costs, although the extent of its use is largely unknown. We examined biosimilar insulin use and its associations with the quality of glycemic control using the Joint Asia Diabetes Evaluation register. MATERIALS AND METHODS: We carried out a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gani, Linsey, Lau, Eric, Luk, Andrea, Sobrepena, Leorino, Tran, Quang Khanh, Kesavadev, Jothydev, Jia, Weiping, Yu, Weinan, Tsang, Chiu Chi, Mukhopadhyay, Monojitketan, Jha, Sujeet, Sheu, Wayne, Ho, Yoon Kun, Nguyen, Thy Khue, Ozaki, Risa, So, Wing Yee, Kwan, Christine, Fu, Amy W C, Mirasol, Roberto, Phatak, Sanjeev Ratnakar, Kumar, Kanakatte Mylariah Prasanna, Aravind, Sosale, Janakiraman, Hari, Chan, Juliana C N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215931/
https://www.ncbi.nlm.nih.gov/pubmed/29575724
http://dx.doi.org/10.1111/jdi.12843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215931/
https://www.ncbi.nlm.nih.gov/pubmed/29575724
http://dx.doi.org/10.1111/jdi.12843

Ejemplares similares